• Dr. Swati Mehta - Patient Experience Specialist, Highly Respected Physician, and Remote Patient Monitoring / Telehealth Expert Joins the Kencor Team
  • Kencor Health is now offering Integration & Professional Services for all Ecosystem products and services.
  • Keep your operations running while your employees, students, staff, and customers stay safe. Kencor COVID-19 Symptom Screening

Remote Patient Monitoring for Oncology

Improve the quality of life for oncology patients through Remote Patient Monitoring. RPM makes various cancer treatments more efficient and bridges communication gaps between patients and providers across all stages of a patient's treatment journey.

Patients no longer need to rely on in-person visits to manage their cancer care.

Remote monitoring for oncology patients typically involves recording patient symptoms and vital signs, and then using an algorithm to detect changes in these measures. Combining RPM and telehealth improves outcomes while simultaneously reducing the cost of care.

Bluetooth-paired devices track valuable patient information that doctors can review and use to make treatment changes and updates. Blood pressure, blood oxygen, glucose levels, body weight, body fat and more can be captured and sent to a care team via a secure connection. "

Improve practice efficiency, workflows, clinical outcomes, and survival

Monitor Patients In Between Treatments
Treating oncology patients on an outpatient basis often leaves patients unmonitored in-between clinic visits. Kencor’s RPM services can simulate the monitoring facilities available in clinics by providing tools to monitor patient health status, self-report irregularities, and virtually discuss concerns with their care team.

Decrease Overall Burden and Lower Healthcare Costs
Minimize healthcare costs by reducing hospitalizations, decreasing the risk from lack of proper patient education, and relieving all involved from incurring unnecessary admission and treatment costs.

Provide Patient Care Anytime, Anywhere
Patients receiving cancer treatment often have a weakened immune system, which increases their susceptibility to foreign pathogens. RPM helps mitigate these risks by eliminating unnecessary clinic visits and decreasing the overall frequency of in person visits.

Receive Daily Patient Updates
Using SAMi’s triage system, Oncologists and related care providers can view all patient-generated medical data in a single dashboard and rapidly prioritize how to effectively care for their patients.

Benefits for the Patient

It can be difficult to grasp all the information that patients receive at consultations. Patient education can be overwhelming for both the patient and their family or caregiver. Some noteworthy roles RPM can play for oncology patients include:

Monitoring Patient Status On A Regular Basis
Any symptoms or side effects of treatment can be promptly reported using Kencor Health’s SAMi™ app. With Kencor’s vital monitoring kit, the patient’s blood pressure, heart rate, oxygen saturation, respiratory rate, and body weight can all be remotely measured and uploaded to the patient’s profile via wireless transmission. Oncologists can view a patient’s vitals on a regular basis, enabling them to analyze the patient’s response to treatment.

Enables Timely Interventions
With SAMi™’s daily patient monitoring, interventions or changes to treatment can be made early on by the oncologist. This reduces the need for frequent readmissions and improve patient outcomes.

Active Patient Engagement
Patients can actively participate in their treatment with the help of SAMi™’s interactive interface. Through patient engagement and communication, providers get a better understanding of the patient’s experience and response to treatment. This, in turn, improves the management of symptoms and side effects that may arise.

The Proof is in the Results:

  • Two randomized controlled trials (RTC) demonstrated overall survival benefits when integrating PROs into routine cancer care
  • RCT at MSK led by Dr. Ethan Basch studied the impact on clinical outcomes using symptom monitoring. Total enrollment of 766 patients from 2007-2014. Patients in the intervention group were prompted on a weekly basis to report on 12 common symptoms using the web-based Symptom Tracking and Reporting (STAR) platform.
  • Results showed an improved HRQL, less frequent ER admissions, longer duration of chemotherapy, and a slight survival advantage (approximately 5 months; P=0.03) in the intervention group
  • Recruitment from five centers in France from 2014-2016, total of 121 patients. Survival benefit in the control group of approximately 7 months (22.5 months in the intervention group vs. 13.5 months in the control group; P = 0.005)